Mehdi Maghbooli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Mehdi Maghbooli has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Nazanin Azizi
Department of Neurology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
5 shared publications - Seyed Nariman Tavakoli Sany
Student Research Committee, Department of Neurology, Faculty of Medicine Zanjan University of Medical Sciences Zanjan Iran
3 shared publications - Abdoreza Ghoreishi
Stroke Research Group, Head of Stroke Care Unit, Department of Neurology, Vali-E-Asr Hospital, School of Medicine, Zanjan University of Medical Science, Zanjan, Iran
2 shared publications Alireza Armani Kian
2 shared publicationsBahareh Safarnejad
Zanjan University of Medical Sciences, Neurology, Zanjan, Iran
2 shared publicationsMehran Yousefi
Zanjan Univ Med Sci, Dept Neurol, Sch Med, Vali E Asr Hosp, Zanjan, Iran
2 shared publications
Latest Publications
- 8 September 2025
- Published by Taylor & Francis in International Journal of Healthcare Management
- Vol. 19 (5) , 972-981
Graded transthoracic echocardiography findings and ischemic stroke characteristics in older adults: A cross-sectional stratified analysis
- 8 September 2025
- Published by Taylor & Francis in International Journal of Healthcare Management
- Vol. 19 (5) , 972-981
Graded transthoracic echocardiography findings and ischemic stroke characteristics in older adults: A cross-sectional stratified analysis
- 30 June 2025
- Published by AMALTEA Medical Publishing House in Lifestyle Medicine Research and Reviews
- Vol. 3 (1-2) , 5-12
Exploring the interplay between inhibitory control, alexithymia, and quality of life in chronic migraine sufferers
Introduction. Chronic migraine significantly impairs quality of life (QoL) and is influenced by psychosocial and behavioral factors. While inhibitory control and alexithymia are associated with emotional regulation and cognitive flexibility, their joint effect on QoL in migraine sufferers is understudied. Understanding these associations may guide lifestyle-based approaches to improve outcomes. Method. This cross-sectional study included 60 patients with chronic migraine recruited from a neurology clinic between October 2021 and January 2022. Participants completed the SF-36 QoL questionnaire, the Toronto Alexithymia Scale (TAS-20), and the Stroop Color and Word Test to assess inhibitory control. Data analysis included correlation and regression models using SPSS v.24. Results. Higher alexithymia and poorer inhibitory control were significantly associated with lower QoL (p < 0.01). Unexpectedly, the externally oriented thinking (EOT) dimension of alexithymia showed a positive association with QoL (p < 0.05), possibly reflecting a coping mechanism that redirects focus away from internal distress. Reaction time in inhibitory control was also a significant predictor of QoL. Conclusion. These findings highlight the relevance of cognitive and emotional processing styles in chronic migraine and suggest that interventions aimed at improving inhibitory control and emotional awareness – such as mindfulness, cognitive training, and stress-reduction strategies – could enhance QoL. Further studies should explore these variables in lifestyle-based, non-pharmacologic interventions.
- 30 June 2025
- Published by AMALTEA Medical Publishing House in Lifestyle Medicine Research and Reviews
- Vol. 3 (1-2) , 5-12
Exploring the interplay between inhibitory control, alexithymia, and quality of life in chronic migraine sufferers
Introduction. Chronic migraine significantly impairs quality of life (QoL) and is influenced by psychosocial and behavioral factors. While inhibitory control and alexithymia are associated with emotional regulation and cognitive flexibility, their joint effect on QoL in migraine sufferers is understudied. Understanding these associations may guide lifestyle-based approaches to improve outcomes. Method. This cross-sectional study included 60 patients with chronic migraine recruited from a neurology clinic between October 2021 and January 2022. Participants completed the SF-36 QoL questionnaire, the Toronto Alexithymia Scale (TAS-20), and the Stroop Color and Word Test to assess inhibitory control. Data analysis included correlation and regression models using SPSS v.24. Results. Higher alexithymia and poorer inhibitory control were significantly associated with lower QoL (p < 0.01). Unexpectedly, the externally oriented thinking (EOT) dimension of alexithymia showed a positive association with QoL (p < 0.05), possibly reflecting a coping mechanism that redirects focus away from internal distress. Reaction time in inhibitory control was also a significant predictor of QoL. Conclusion. These findings highlight the relevance of cognitive and emotional processing styles in chronic migraine and suggest that interventions aimed at improving inhibitory control and emotional awareness – such as mindfulness, cognitive training, and stress-reduction strategies – could enhance QoL. Further studies should explore these variables in lifestyle-based, non-pharmacologic interventions.
- Open Access
- 11 February 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (2) , e70324
Determining the Diagnostic Value of Venous Sinus Density Indices in Non‐Contrast Brain CT Scan for Early Diagnosis of Cerebral Venous Sinus Thrombosis
Background and Aim: A non‐contrast brain CT Non‐contrast computed tomography (NCCT) scan is a valuable and cost‐effective way to detect cerebral venous sinus thrombosis (CVST) during its acute phase. The goal of this study was to evaluate how effective this diagnostic approach is, including its various density indices, to enable a more precise and timely diagnosis of this debilitating condition.Method: This retrospective case‐control study was conducted on 88 patients with suspected acute CVST. We analyzed NCCT scans of patients with suspected CVST using a Bayesian regression model with a 95% confidence level. We also conducted ROC analysis in R4.1.0 to determine the optimal cut‐off point.Result: We discovered a significant variance in the average sinus attenuation when comparing patients with acute CVST (p < 0.001). By utilizing an optimal cutoff of 61 HU (Hounsfield unit), we achieved sensitivities of 77.1% and specificities of 92.5% for average sinus attenuation. In addition, the optimal cutoff for standardized parameters included the ratios of HU/H (Hematocrit), HU/ICA (internal carotid artery), HU/BA (basilar artery), HU/FRONTAL lobe, HU/TEMPORAL lobe, and HU–BA, which were 1.41, 1.52, 1.63, 1.6, 1.6, and 23, respectively (p < 0.001). Area under the ROC curve for absolute venous Hounsfield was 0.88.Conclusion: NCCT is a reliable diagnostic approach for acute cerebral venous sinus thrombosis in emergency scenarios. Standardized parameters of absolute Hounsfield unit venous sinus thrombosis increase diagnosis accuracy. It is suggested to use these parameters as a complement to each other for more accurate diagnosis.
- 11 February 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (2) , e70324
Open AccessDetermining the Diagnostic Value of Venous Sinus Density Indices in Non‐Contrast Brain CT Scan for Early Diagnosis of Cerebral Venous Sinus Thrombosis
Background and Aim: A non‐contrast brain CT Non‐contrast computed tomography (NCCT) scan is a valuable and cost‐effective way to detect cerebral venous sinus thrombosis (CVST) during its acute phase. The goal of this study was to evaluate how effective this diagnostic approach is, including its various density indices, to enable a more precise and timely diagnosis of this debilitating condition.Method: This retrospective case‐control study was conducted on 88 patients with suspected acute CVST. We analyzed NCCT scans of patients with suspected CVST using a Bayesian regression model with a 95% confidence level. We also conducted ROC analysis in R4.1.0 to determine the optimal cut‐off point.Result: We discovered a significant variance in the average sinus attenuation when comparing patients with acute CVST (p < 0.001). By utilizing an optimal cutoff of 61 HU (Hounsfield unit), we achieved sensitivities of 77.1% and specificities of 92.5% for average sinus attenuation. In addition, the optimal cutoff for standardized parameters included the ratios of HU/H (Hematocrit), HU/ICA (internal carotid artery), HU/BA (basilar artery), HU/FRONTAL lobe, HU/TEMPORAL lobe, and HU–BA, which were 1.41, 1.52, 1.63, 1.6, 1.6, and 23, respectively (p < 0.001). Area under the ROC curve for absolute venous Hounsfield was 0.88.Conclusion: NCCT is a reliable diagnostic approach for acute cerebral venous sinus thrombosis in emergency scenarios. Standardized parameters of absolute Hounsfield unit venous sinus thrombosis increase diagnosis accuracy. It is suggested to use these parameters as a complement to each other for more accurate diagnosis.
- Open Access
- 25 August 2023
- Published by Wiley
Assessment of Structural Connectivity and Brain Volumes after tDCS in Stroke: A Machine-learning Method
Background: Stroke causes numerous symptoms, including impaired motor skills, sensation languages, and cognitive functions. Previous studies revealed non-invasive brain stimulation techniques could enhance sensory, cognitive, and motor function. Objective: This study aimed to evaluate the effectiveness of transcranial direct current stimulation on functional communication, motor learning, and cognitive function in patients with ischemic stroke. Methods and Materials: The research method of this study was quasi-experimental with pre-test and post-test designs with three groups. Twenty-four patients were enrolled at the beginning. After written consent before the intervention, the Fugl-Meyer Assessment, Montreal Cognitive Assessment Test, and Mini-Mental State Exam were performed at three different time points. Furthermore, functional and structural neuroimaging (DTI, fMRI) were exploited before and after the intervention. Regarding the intervention process, transcranial direct current stimulation (tDCS) was used for twelve 30-minute daily sessions for the patients. Data were analyzed via in-house MATLAB-SPM12, FSL, and scikit-learn. Results: The figures for the FMA test of the active group increased after the intervention (P<0.05). Additionally, the figure for both screening tests increased after the treatment in the active group (P<0.05). Regarding the results of DTI, a significant difference was found in some regions, such as the right inferior occipital. Moreover, the best results were achieved by Random Forest, CatBoost, and XGBoost models in classifying groups by DTI data. Conclusion: Transcranial direct-current stimulation has been proven to be an effective rehabilitation for post-stroke impairments. We assessed the different structural and functional neuroimaging methods to determine which could display the effect of tDCS.
- 25 August 2023
- Published by Wiley
Open AccessAssessment of Structural Connectivity and Brain Volumes after tDCS in Stroke: A Machine-learning Method
Background: Stroke causes numerous symptoms, including impaired motor skills, sensation languages, and cognitive functions. Previous studies revealed non-invasive brain stimulation techniques could enhance sensory, cognitive, and motor function. Objective: This study aimed to evaluate the effectiveness of transcranial direct current stimulation on functional communication, motor learning, and cognitive function in patients with ischemic stroke. Methods and Materials: The research method of this study was quasi-experimental with pre-test and post-test designs with three groups. Twenty-four patients were enrolled at the beginning. After written consent before the intervention, the Fugl-Meyer Assessment, Montreal Cognitive Assessment Test, and Mini-Mental State Exam were performed at three different time points. Furthermore, functional and structural neuroimaging (DTI, fMRI) were exploited before and after the intervention. Regarding the intervention process, transcranial direct current stimulation (tDCS) was used for twelve 30-minute daily sessions for the patients. Data were analyzed via in-house MATLAB-SPM12, FSL, and scikit-learn. Results: The figures for the FMA test of the active group increased after the intervention (P<0.05). Additionally, the figure for both screening tests increased after the treatment in the active group (P<0.05). Regarding the results of DTI, a significant difference was found in some regions, such as the right inferior occipital. Moreover, the best results were achieved by Random Forest, CatBoost, and XGBoost models in classifying groups by DTI data. Conclusion: Transcranial direct-current stimulation has been proven to be an effective rehabilitation for post-stroke impairments. We assessed the different structural and functional neuroimaging methods to determine which could display the effect of tDCS.
- Open Access
- 3 June 2023
- Published by Brieflands in Archives of Neuroscience
- Vol. 10 (2)
Serum Levels of Ferritin, Iron, and Total Iron Binding Capacity in Cerebral Venous Sinus Thrombosis
Background: Cerebral venous sinus thrombosis (CVST) is a potentially life-threatening condition with a wide range of clinical presentations, from localized headache (the most common symptom) to mental status disturbances, seizures, and coma. Objectives: The main purpose of this study was to evaluate serum levels of ferritin, iron, and total iron binding capacity (TIBC) and their possible relationship with different parameters in CVST patients. Methods: Thirty patients with a definitive diagnosis of CVST based on brain magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) results participated in the study. During the first 24 hours after admission, 5 cc of blood sample was collected from each patient and delivered to the laboratory to measure serum ferritin, iron, and TIBC levels. Results: Twenty-four women and six men (mean age: 42.6 ± 16.33 years) participated in the study. The mean levels of serum iron, TIBC, and ferritin were within normal ranges (99.40 ± 29.97 mg/dL, 324.50 ± 49.57 mg/dL, and 87.36 ± 88.84 ng/mL, respectively). There were no significant relationships between serum ferritin, iron, TIBC levels, oral contraceptive pills consumption, history of CVST or cerebrovascular accident (CVA), underlying diseases, and the involved sinus. Conclusions: The current study showed no possible benefits of using serum ferritin, iron, and TIBC indices in CVST patients.
- 3 June 2023
- Published by Brieflands in Archives of Neuroscience
- Vol. 10 (2)
Open AccessSerum Levels of Ferritin, Iron, and Total Iron Binding Capacity in Cerebral Venous Sinus Thrombosis
Background: Cerebral venous sinus thrombosis (CVST) is a potentially life-threatening condition with a wide range of clinical presentations, from localized headache (the most common symptom) to mental status disturbances, seizures, and coma. Objectives: The main purpose of this study was to evaluate serum levels of ferritin, iron, and total iron binding capacity (TIBC) and their possible relationship with different parameters in CVST patients. Methods: Thirty patients with a definitive diagnosis of CVST based on brain magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) results participated in the study. During the first 24 hours after admission, 5 cc of blood sample was collected from each patient and delivered to the laboratory to measure serum ferritin, iron, and TIBC levels. Results: Twenty-four women and six men (mean age: 42.6 ± 16.33 years) participated in the study. The mean levels of serum iron, TIBC, and ferritin were within normal ranges (99.40 ± 29.97 mg/dL, 324.50 ± 49.57 mg/dL, and 87.36 ± 88.84 ng/mL, respectively). There were no significant relationships between serum ferritin, iron, TIBC levels, oral contraceptive pills consumption, history of CVST or cerebrovascular accident (CVA), underlying diseases, and the involved sinus. Conclusions: The current study showed no possible benefits of using serum ferritin, iron, and TIBC indices in CVST patients.
- Open Access
- 1 January 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (2) , e2860
Effect of add‐on melatonin on seizure outcomes and quality of sleep in epilepsy with idiopathic generalized tonic‐clonic seizures alone in adult patients: Cross‐sectional, randomized, double‐blind, placebo‐controlled clinical trial
Background: Effective treatment of epilepsy is a major challenge in the field of neurology. Studies have suggested that melatonin can work in epilepsy with a good safety profile.Objectives: This study was performed to determine the effectiveness of melatonin in seizure outcomes, as well as the quality of sleep in patients with generalized epilepsy.Methods: In this cross‐over clinical trial study, 60 patients with epilepsy with idiopathic generalized tonic‐clonic seizures alone (EGTCS) and under valproic acid treatment received either melatonin or placebo with a washout period of 2 weeks intermittently. Outcome variables included a reduction in the severity and frequency of epilepsy besides improvement in electroencephalogram (EEG) abnormalities and sleep quality.Results: By adding melatonin, a decrease in the mean severity score of epilepsy (according to the Chalfont questionnaire) was 32.33 ± 9.24, while it was 5.58 ± 14.28 in treatment with placebo (p = .002). Evaluation of the number of attacks and EEG results did not disclose any therapeutic efficacy in treatment with melatonin versus placebo. The quality of sleep improved in 40% (first round) and 53.4% (second round) of subjects who received melatonin (p < .001).Conclusions: Considering that the addition of melatonin to routine anti‐seizure treatment was effective in reducing the severity of epilepsy and improving sleep quality, it seems that melatonin can be useful as an adjunct therapy for EGTCS in well‐defined circumstances.
- 1 January 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (2) , e2860
Open AccessEffect of add‐on melatonin on seizure outcomes and quality of sleep in epilepsy with idiopathic generalized tonic‐clonic seizures alone in adult patients: Cross‐sectional, randomized, double‐blind, placebo‐controlled clinical trial
Background: Effective treatment of epilepsy is a major challenge in the field of neurology. Studies have suggested that melatonin can work in epilepsy with a good safety profile.Objectives: This study was performed to determine the effectiveness of melatonin in seizure outcomes, as well as the quality of sleep in patients with generalized epilepsy.Methods: In this cross‐over clinical trial study, 60 patients with epilepsy with idiopathic generalized tonic‐clonic seizures alone (EGTCS) and under valproic acid treatment received either melatonin or placebo with a washout period of 2 weeks intermittently. Outcome variables included a reduction in the severity and frequency of epilepsy besides improvement in electroencephalogram (EEG) abnormalities and sleep quality.Results: By adding melatonin, a decrease in the mean severity score of epilepsy (according to the Chalfont questionnaire) was 32.33 ± 9.24, while it was 5.58 ± 14.28 in treatment with placebo (p = .002). Evaluation of the number of attacks and EEG results did not disclose any therapeutic efficacy in treatment with melatonin versus placebo. The quality of sleep improved in 40% (first round) and 53.4% (second round) of subjects who received melatonin (p < .001).Conclusions: Considering that the addition of melatonin to routine anti‐seizure treatment was effective in reducing the severity of epilepsy and improving sleep quality, it seems that melatonin can be useful as an adjunct therapy for EGTCS in well‐defined circumstances.
- Open Access
- 31 October 2022
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 17 (5)
Comparison of Herpes Simplex Virus Reactivation Frequency in Acute Idiopathic Cranial Mononeuropathy and Normal Population by Serological Assay
Background: Herpes simplex virus (HSV) is a neurotropic DNA virus with a high prevalence. Following primary infection, HSV remains dormant in the neural ganglia. Secondary infection can emerge after the reactivation of latent infection, presenting as neurological manifestations. Previous studies have demonstrated the relationship between HSV reactivation and selective involvement of cranial nerves. Depending on the affected nerve, cranial mononeuropathies can present with symptoms, including diplopia, blurred vision, vertigo, unilateral facial palsy, speech impairment, swallowing difficulties, and hoarseness. Objectives: This study used a serological assay to compare HSV reactivation frequency between patients with recent idiopathic cranial mononeuropathies and normal individuals. Methods: Plasma samples from 35 idiopathic cranial mononeuropathy cases (57.2% women, mean age 58.37 years) and 35 age and sex-matched healthy controls were analyzed for anti-HSV immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies by enzyme-linked immunosorbent assay (ELISA). Results: Anti-HSV IgG antibody was positive in 91.4% of patients and 88.6% of controls. The mean serum anti-HSV IgG antibody level was significantly higher in patients (146.78 ± 60 RU/mL) than in the controls (130.61 ± 52.99 RU/mL) (P-value = 0.037). Anti-HSV IgM antibody was positive in 37.1% of patients and 14.3% of controls (P = 0.042). Conclusions: The frequency of HSV reactivation was significantly higher in patients with acute idiopathic cranial mononeuropathy than in the healthy controls, indicating the possible role of HSV as an etiology of cranial mononeuropathy.
- 31 October 2022
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. 17 (5)
Open AccessComparison of Herpes Simplex Virus Reactivation Frequency in Acute Idiopathic Cranial Mononeuropathy and Normal Population by Serological Assay
Background: Herpes simplex virus (HSV) is a neurotropic DNA virus with a high prevalence. Following primary infection, HSV remains dormant in the neural ganglia. Secondary infection can emerge after the reactivation of latent infection, presenting as neurological manifestations. Previous studies have demonstrated the relationship between HSV reactivation and selective involvement of cranial nerves. Depending on the affected nerve, cranial mononeuropathies can present with symptoms, including diplopia, blurred vision, vertigo, unilateral facial palsy, speech impairment, swallowing difficulties, and hoarseness. Objectives: This study used a serological assay to compare HSV reactivation frequency between patients with recent idiopathic cranial mononeuropathies and normal individuals. Methods: Plasma samples from 35 idiopathic cranial mononeuropathy cases (57.2% women, mean age 58.37 years) and 35 age and sex-matched healthy controls were analyzed for anti-HSV immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies by enzyme-linked immunosorbent assay (ELISA). Results: Anti-HSV IgG antibody was positive in 91.4% of patients and 88.6% of controls. The mean serum anti-HSV IgG antibody level was significantly higher in patients (146.78 ± 60 RU/mL) than in the controls (130.61 ± 52.99 RU/mL) (P-value = 0.037). Anti-HSV IgM antibody was positive in 37.1% of patients and 14.3% of controls (P = 0.042). Conclusions: The frequency of HSV reactivation was significantly higher in patients with acute idiopathic cranial mononeuropathy than in the healthy controls, indicating the possible role of HSV as an etiology of cranial mononeuropathy.
- 1 July 2022
- Published by Elsevier in Neurología Argentina
- Vol. 14 (3) , 147-154
Interrelation between IFN-γ levels and severity of electrodiagnostic abnormality in acute phase of Bell's palsy
- 1 July 2022
- Published by Elsevier in Neurología Argentina
- Vol. 14 (3) , 147-154
Interrelation between IFN-γ levels and severity of electrodiagnostic abnormality in acute phase of Bell's palsy
- Open Access
- 29 July 2021
- Published by Vilnius University Press in Acta medica Lituanica
- Vol. 28 (2) , 15
Is There Any Relation between Serum Levels of Interleukin-10 and Neurophysiological Abnormalities in Bell’s Palsy?
Background: Bell’s palsy is the most common cause of peripheral facial palsy. The etiology and treatment of Bell’s palsy are still controversial. Previous studies emphasize the role of herpes simplex and herpes zoster viruses in this ailment. The role of Interleukin-10 (IL-10) in Bell’s palsy is yet unknown, and few studies have shed light on the matter. This study intended to assess the prognostic value of IL-10 and its relation to the intensity of electrodiagnostic abnormalities and evaluate its potential use as a factor for judging the need for medical or surgical interventions.Materials and Methods: 30 patients in the acute phase of Bell’s palsy participated in this study. Peripheral blood samples were obtained for IL-10 assessment within the first 72 hours (before commencing treatment), and a nerve conduction study (NCS) was performed six days after symptom onset.Results: There was no significant correlation between IL-10 serum levels and the severity of nerve conduction pathology in Orbicularis oculi and Orbicularis oris muscles. Also, IL-10 serum levels did not show any meaningful relationships with participants’ age, gender, or symptoms.Conclusion: The IL-10 serum levels are not relevant to the pathology of Bell’s palsy, and the assessment of IL-10 serum levels cannot be used as an alternative to NCS for evaluating the severity of acute Bell’s palsy.
- 29 July 2021
- Published by Vilnius University Press in Acta medica Lituanica
- Vol. 28 (2) , 15
Open AccessIs There Any Relation between Serum Levels of Interleukin-10 and Neurophysiological Abnormalities in Bell’s Palsy?
Background: Bell’s palsy is the most common cause of peripheral facial palsy. The etiology and treatment of Bell’s palsy are still controversial. Previous studies emphasize the role of herpes simplex and herpes zoster viruses in this ailment. The role of Interleukin-10 (IL-10) in Bell’s palsy is yet unknown, and few studies have shed light on the matter. This study intended to assess the prognostic value of IL-10 and its relation to the intensity of electrodiagnostic abnormalities and evaluate its potential use as a factor for judging the need for medical or surgical interventions.Materials and Methods: 30 patients in the acute phase of Bell’s palsy participated in this study. Peripheral blood samples were obtained for IL-10 assessment within the first 72 hours (before commencing treatment), and a nerve conduction study (NCS) was performed six days after symptom onset.Results: There was no significant correlation between IL-10 serum levels and the severity of nerve conduction pathology in Orbicularis oculi and Orbicularis oris muscles. Also, IL-10 serum levels did not show any meaningful relationships with participants’ age, gender, or symptoms.Conclusion: The IL-10 serum levels are not relevant to the pathology of Bell’s palsy, and the assessment of IL-10 serum levels cannot be used as an alternative to NCS for evaluating the severity of acute Bell’s palsy.